• by Bruce Carlson
  • January 22 2019


Kalorama Expands Analytical and Life Science Instrumentation Research - Introducing Partner Publisher SDI

Kalorama Expands Analytical and Life Science Instrumentation Research - Introducing Partner Publisher SDI

As part of Kalorama Information's acquisition by Bioinformatics Inc, the brand can offer an expanded schedule and in-depth analysis of life science/analytical instrumentation through its partner publication, Strategic Directions International SDi.


New CVS Hub Stores, NASH Drugs, Liquid Biopsy, Illumina Chip, Smokeless Tobacco Reduction, Among Developments at JPM and Biotech Showcase

New CVS Hub Stores, NASH Drugs, Liquid Biopsy, Illumina Chip, Smokeless Tobacco Reduction, Among Developments at JPM and Biotech Showcase

Drugs for an underserved liver disease class, continued liquid biopsy development, a new chip to improve reads and run lengths for NGS and many company updates were on Kalorama's radar at the 37th J.P. Morgan Healthcare Conference in San Francisco last week.

  • by Bruce Carlson
  • January 7 2019


$115 Billion in China Biotech Investments, New Apps and Devices, Biogen ALZ Deals Lead Early JPMHC / Biotech Showcase News

China biotech numbers from 2018 roll in and the news is good, a headache app and other trends before the show truly begins.

  • by Bruce Carlson
  • January 2 2019
  • IVD


2019 Biotech Showcase Developments of Note, with a Particular IVD Focus

2019 Biotech Showcase Developments of Note, with a Particular IVD Focus

Kalorama Information will be covering the 2019 Biotech Showcase, which is concurrent with the J.P. Morgan Healthcare Conference, in San Francisco January 7-9th. Here are some interesting developments that we will report on as the meeting proceeds.